Clinical trials are crucial for discovering new treatments and improving care.
By participating, you have the opportunity to access investigational therapies and contribute to groundbreaking research that could lead to better treatments for Alzheimer’s.
Explore current trials and see how you can play a part in advancing the fight against Alzheimer’s disease. Your involvement can make a difference.
Clinical Trials
Join the Fight against Alzheimer’s
ALTER-AD
The purpose of this study is to evaluate the effects of tricaprilin (20 g twice a day) on cognition, activities of daily living, resource utilisation, safety and tolerability, in subjects with mild to moderately severe probable AD. This is a randomised, double-blind, placebo-controlled, parallel-group, multi-centre design in up to 535 participants. If you have any questions about our investigational product candidates and/or our ongoing clinical trials
Korean 
English